wsd0922-fu
EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer
Wayshine Biopharm, Inc.Phase 2
—
Rating in progress
wsd0922-fu in EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active